![Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group - The Lancet Oncology Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group - The Lancet Oncology](https://www.thelancet.com/cms/asset/57dec39c-15d7-4f9d-b2e8-c9099285a0be/gr1.jpg)
Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group - The Lancet Oncology
![Inhibition of BMP2 and BMP4 Represses Barrett's Esophagus While Enhancing the Regeneration of Squamous Epithelium in Preclinical Models - ScienceDirect Inhibition of BMP2 and BMP4 Represses Barrett's Esophagus While Enhancing the Regeneration of Squamous Epithelium in Preclinical Models - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352345X23000036-fx1.jpg)
Inhibition of BMP2 and BMP4 Represses Barrett's Esophagus While Enhancing the Regeneration of Squamous Epithelium in Preclinical Models - ScienceDirect
![HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study - The Lancet HIV HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study - The Lancet HIV](https://www.thelancet.com/cms/attachment/1fe4b24a-6816-4521-8fdd-bc191425b033/gr1_lrg.jpg)